BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 358479)

  • 21. [Indications and results of radiotherapy after exeresis for bronchial cancer].
    Herdly J; Pillement P; Morand G; Pauli G; Roeslin N; Oudet P; Witz JP
    Bronches; 1974; 24(2):110-5. PubMed ID: 4421060
    [No Abstract]   [Full Text] [Related]  

  • 22. BCG plus levamisole following irradiation of advanced squamous bronchial carcinoma.
    Pines A
    Int J Radiat Oncol Biol Phys; 1980 Aug; 6(8):1041-2. PubMed ID: 7419462
    [No Abstract]   [Full Text] [Related]  

  • 23. [The E.O.R.T.C. plan of study of adjuvant therapeutics for resected bronchial epidermoid cancers].
    Israel L
    Bronches; 1974; 24(2):101-4. PubMed ID: 4417391
    [No Abstract]   [Full Text] [Related]  

  • 24. Cell-mediated immune response in patients with bronchial carcinoma. Relation between clinical parameters and various immunological tests for immune status investigation.
    Jansen HM; Esselink MT; Orie NG; The TH
    Neth J Med; 1979; 22(1):1-9. PubMed ID: 216940
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunology of bronchial carcinoma.
    Evans DA
    Thorax; 1976 Oct; 31(5):493-506. PubMed ID: 793085
    [No Abstract]   [Full Text] [Related]  

  • 26. The prognostic significance of DHS skin tests in patients with carcinoma of bronchus.
    Anthony HM; Templeman GH; Madsen KE; Mason MK
    Cancer; 1974 Dec; 34(6):1901-6. PubMed ID: 4373163
    [No Abstract]   [Full Text] [Related]  

  • 27. Harmful effects of i.v. Corynebacterium Parvum given at the same time as cyclophosphamide in patients with squamous-cell carcinoma of the bronchus.
    von Blomberg BM; Glerum J; Croles JJ; Stam J; Drexhage HA
    Br J Cancer; 1980 Apr; 41(4):609-17. PubMed ID: 7387858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of immune status in bronchial neoplasms: contribution of the E-rosette test. 70 cases].
    Hainaut J; Messner P; Delaval P; Haguenauer G; Pellegrin J; Kermarec J
    Ann Med Interne (Paris); 1978 Dec; 129(12):695-9. PubMed ID: 747256
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bronchus carcinoma and clinical judgment].
    Sluiter HJ
    Ned Tijdschr Geneeskd; 1973 Mar; 117(10):373-5. PubMed ID: 4688741
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combination chemotherapy and surgery in the treatment of epidermoid bronchial carcinoma].
    Raut Y; Nguyen Huu ; Barra JA; Guillerm D; Clavier J; Brière J; Larzul JJ; Rio G
    Ann Chir; 1985 Mar; 39(2):141-6. PubMed ID: 4004066
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adjuvant therapy of bronchial carcinoma with special attention to immunotherapy].
    Drings P
    Aktuelle Probl Chir Orthop; 1982; 22():30-5. PubMed ID: 6121510
    [No Abstract]   [Full Text] [Related]  

  • 32. E and EAC rosetting lymphocytes in patients with carcinoma of bronchus. II. A sequential study of thirty patients: effect of BCG.
    Anthony HM; Kirk JA; Madsen KE; Mason MK; Templeman GH
    Clin Exp Immunol; 1975 Apr; 20(1):41-54. PubMed ID: 54235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current status of immunotherapy of malignant tumors].
    Flad HD; Betzler M; Herfarth C
    Chirurg; 1979 Jan; 50(1):11-5. PubMed ID: 367730
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjuvant chemoimmunotherapy in advanced lesions of the head and neck.
    Eilber FR; Morton DL
    AJR Am J Roentgenol; 1976 May; 126(5):1082-7. PubMed ID: 178233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease.
    Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed hypersensitivity in patients with bronchial carcinoma.
    Pauwels R; van der Straeten M
    Scand J Respir Dis; 1975 Sep; 56(3):160-4. PubMed ID: 1162307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [5 years of nonspecific active immunotherapy with a transformed mycobacterium in operated primary bronchial cancers. Study of postoperative survival of from 1 to 3 years].
    Djurovic V; Decroix G
    Ann Med Interne (Paris); 1978 Apr; 129(4):237-42. PubMed ID: 666198
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
    Winters WD; Lamm DL
    Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is immunotherapy useful in bronchial carcinoma?].
    Geraint JD
    Schweiz Med Wochenschr; 1977 Apr; 107(13):421-2. PubMed ID: 300502
    [No Abstract]   [Full Text] [Related]  

  • 40. Complications of intrapleural BCG in the treatment of operable non-small-cell bronchial carcinoma.
    Law MR; Lam WK; Studdy PR; Pugsley WB; Hodson ME
    Br J Dis Chest; 1982 Apr; 76(2):151-6. PubMed ID: 7093133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.